Induction chemotherapy (IC) with docetaxel/cisplatin/5-fluorouracil (TPF) followed by cisplatin-containing concomitant chemoradiotherapy (CRT) in fit patients with locally advanced head and neck cancer (LAHNC): The CONDOR study-A study of the Dutch Head and Neck Society

被引:0
|
作者
Driessen, Chantal
De Boer, J. P.
Gelderblom, Hans
Rasch, Coen R. N.
de Jong, Martin
Verbist, Berit M.
Tesselaar, Margot Et
Van der Graaf, Winette T. A.
Kaanders, J. H.
Van Herpen, Carla M. L. -
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands
[2] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Radiat Oncol, Leiden, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands
[6] Leiden Univ, Med Ctr, Leiden, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6057
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer
    Okano, Susumu
    Enokida, Tomohiro
    Onoe, Takuma
    Ota, Yosuke
    Motegi, Atsushi
    Zenda, Sadamoto
    Akimoto, Tetsuo
    Tahara, Makoto
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (07) : 789 - 797
  • [22] Phase II/III trial of induction chemotherapy (ICT) with cisplatin/5-fluorouracil (PF) vs. docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs. CRT for unresectable locally advanced head and neck cancer (LAHNC).
    Hitt, R
    Grau, J
    Lopez-Pousa, A
    Berrocal, A
    Sastre, J
    Belon, J
    Escobar, Y
    Carles, J
    Cortes-Funes, H
    Cruz, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 519S - 519S
  • [23] Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer
    Hitt, R
    López-Pousa, A
    Martínez-Trufero, J
    Escrig, V
    Carles, J
    Rizo, A
    Isla, D
    Vega, ME
    Martí, JL
    Lobo, F
    Pastor, P
    Valentí, V
    Belón, J
    Sánchez, MA
    Chaib, C
    Pallarés, C
    Antón, A
    Cervantes, A
    Paz-Ares, L
    Cortés-Funes, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8636 - 8645
  • [24] Adjuvant docetaxel, cisplatin and 5-Fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck
    Baghi, M
    Hambek, M
    May, A
    Radeloff, A
    Gstoettner, W
    Knecht, R
    ANTICANCER RESEARCH, 2006, 26 (1B) : 559 - 563
  • [25] COMPARATIVE COST ANALYSIS FOR DOCETAXEL, CISPLATIN AND 5-FLUOROURACIL (TPF) AND CISPLATIN AND 5-FLUOROURACIL (PF) FOR HEAD AND NECK CANCER PATIENTS
    Pantarotto, M.
    Castro, A. F.
    Estevinho, F.
    Azevedo, I.
    Dinis, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 327 - 328
  • [26] Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, F.
    Selzer, E.
    Berghold, A.
    Reinisch, S.
    de Vries, A.
    Greil, R.
    Bachtiary, B.
    Tinchon, C.
    Anderhuber, W.
    Burian, M.
    Kasparek, A. K.
    Elsaesser, W.
    Kainz, H.
    Riedl, R.
    Kapp, K.
    Kopp, M.
    Kornek, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 273 - 273
  • [27] INDUCTION CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN AND 5-FLUOROURACIL FOLLOWED BY RADIOTHERAPY WITH CETUXIMAB FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Keil, F.
    Selzer, E.
    Berghold, A.
    Kapp, K.
    De Vries, A.
    Greil, R.
    Reinisch, S.
    Anderhuber, W.
    Burian, M.
    Kornek, G. V.
    ANNALS OF ONCOLOGY, 2012, 23 : 340 - 341
  • [28] Induction chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil followed by radiotherapy with Cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, F.
    Selzer, E.
    Berghold, A.
    Reinisch, S.
    Kapp, K.
    De Vries, A.
    Greil, R.
    Bachtiary, B.
    Tinchon, C.
    Anderhuber, W.
    Burian, M.
    Kasparek, A-K
    Elsaesser, W.
    Kainz, H.
    Kopp, M.
    Kornek, G.
    ONKOLOGIE, 2012, 35 : 194 - 194
  • [29] Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, Felix
    Selzer, Edgar
    Berghold, Andrea
    Reinisch, Sabine
    Kapp, Karin S.
    De Vries, Alexander
    Greil, Richard
    Bachtiary, Barbara
    Tinchon, Christoph
    Anderhuber, Wolfgang
    Burian, Martin
    Kasparek, Anne-Katrin
    Elsaesser, Wolfgang
    Kainz, Herbert
    Riedl, Regina
    Kopp, Michael
    Kornek, Gabriela
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (02) : 352 - 359
  • [30] Feasibility and efficacy of chemoradiotherapy with concurrent split-dose cisplatin after induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for locally advanced head and neck cancer
    Yokota, Tomoya
    Shibata, Masayuki
    Hamauchi, Satoshi
    Shirasu, Hiromichi
    Onozawa, Yusuke
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Kawakami, Takeshi
    Furuta, Mitsuhiro
    Inoue, Hiroto
    Fushiki, Kunihiro
    Onitsuka, Tetsuro
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 13 (04) : 1 - 6